We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
NEXTSTELLIS (Mayne Pharma International Pty Ltd)
Product name
NEXTSTELLIS
Date registered
Evaluation commenced
Decision date
Approval time
200 (255 working days)
Active ingredients
estetrol monohydrate; drospirenone
Registration type
NCE/NBE
Indication
NEXTSTELLIS (film-coated tablet) is indicated for use by women of reproductive potential to prevent pregnancy.